💙 🔷 Not impressed by Big Tech in Q3? Explore these Blue Chip Bargains insteadUnlock them all

Microcap stock jumps 7% after receiving export order worth ₹ 84 lakh for toothpaste

Published 13-08-2024, 03:00 pm
Microcap stock jumps 7% after receiving export order worth ₹ 84 lakh for toothpaste
VEEH
-

In Tuesday’s trading session, the shares of a leading provider of ayurvedic, herbal & cosmetics healthcare surged by 7.8 percent to Rs. 24.7 on BSE, after the company secured an export order worth Rs. 84 lakh from a Top USA Institutional Supplier.

At 02:15 p.m., the shares of VeerHealth Care Limited were trading in the green at Rs. 24.44, up by 6.7 percent, compared to its previous closing price of Rs. 22.91, with a market cap of Rs. 49 crores.

Is VeerHealth Care a buy or sell? What is its Fair Value? What are the company's health parameters? What are the positive and negative factors driving the company -- ProTips? Know all the answers on the company's overview page here.

What’s the News:

According to the latest regulatory filings with the BSE, VeerHealth Care Limited announced receiving an export order of a new toothpaste variant valued at US$ 101680 (~₹84 Lakhs) from a leading institutional supplier in the USA.

With this order of a new variant, the company has acquired orders in all the variants marketed by the client in the USA. The order will be executed within a period of 3 months.

Previous News:

On 22nd July, Veerhealth Care Limited announced securing a repeat order worth Rs. 121 lakhs in the hair care category from one of the leading corporate healthcare companies.

On 9th August, Veerhealth Care Limited announced initial expansion plans, which include acquiring an additional 27,451 sq. ft. of land adjacent to its existing manufacturing facility in Vapi, Gujarat.

The acquisition will enable the establishment of new manufacturing lines that comply with CGMP norms as required by the USFDA, addressing the rising demand from the USA, East & North African markets.

Following the expansion, the total plot area stood at 58,623 sq. ft., combining the current 31,172 sq. ft. with the newly acquired 27,451 sq. ft.

The total constructed area will increase to 90,000 sq. ft., with 60,000 sq. ft. from the existing facility and 30,000 sq. ft. from the new construction.

This strategic move is expected to support Veerhealth Care Limited achieve a revenue target of Rs. 100 crore over the next 2 to 3 years, with a 10 percent PAT margin.

Financials:

Financially, the company experienced a fall in its revenue from operations, showing a year-on-year decline of 8.8 percent from Rs. 3.73 crores in Q4 FY22-23 to Rs. 3.4 crores in Q4 FY23-24.

Similarly, its net profit decreased during the same period from a profit of Rs. 1.04 crores to a loss of Rs. 0.55 crores.

Stock performance:

The stock has delivered positive returns of nearly 26 percent in one year as well as around 13.5 percent returns in the last six months. So far in 2024, the shares of VeerHealth Care have given about 15.4 percent of positive returns.

About the company:

VeerHealth Care Limited is engaged in the business of manufacturing and supply of ayurvedic medicines, oral care products and personal care products under the brand ‘Ayuveer’.

Some of the company’s products include health care, oral care & personal care products like shampoos, conditioners, lip balms, creams, scrubs, bath salts, shower gels, lotions, ayurvedic toothpaste and much more under ayurvedic & cosmetic license.

The company was originally incorporated in 1992 as Niyati Leasing Limited with the purpose of starting a business in investment and finance, but in 2013, the management decided to diversify the business activities and changed its main object to the Pharma sector.

Written by Shivani Singh

Disclaimer

The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.

The post Microcap stock jumps 7% after receiving export order worth ₹ 84 lakh for toothpaste appeared first on Trade Brains.

Read More

To understand more about InvestingPro, watch this video: https://www.youtube.com/watch?v=_WfQcN5vjI

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.